期刊文献+

多索茶碱缓释胶囊的制备与体外释放度考察 被引量:3

Study on Preparation and in Vitro Release of Doxofylline Sustained-release Capsules
下载PDF
导出
摘要 目的 :制备多索茶碱缓释胶囊 ,考察其体外释放度。方法 :采用滚动成丸法 ,以微晶纤维素为种核 ,5 %羟丙基甲基纤维素为粘合剂 ,在包衣锅内将多索茶碱泛制成丸 ,再用EudragitRS100包衣 ,装胶囊。采用紫外分光光度法测定多索茶碱的溶出量 ,作为多索茶碱缓释胶囊的释放度测定指标。结果 :本法制备的缓释胶囊其释放度在2、6、10h时分别为20 %~40 %、40 %~80 %、80 %以上。结论 :制备工艺可行 ,重现性好 ,所制备的多索茶碱缓释胶囊体外溶出具有明显的缓释特性。 OBJECTIVE:To prepare the doxofylline sustained-release capsules and evaluate it's in vitro release.METH_ ODS:The doxofylline sustained pellets were developed by rolling technique and coated by Eudragit RS100.UV-spectropho tometry was adopted to determine the dissolubility of doxofylline,which marked the release profiles of that capˉsules.RESULTS:The dissolubilities of the capsules were20%~40%,40%~80%and more than80%at2h,6h and10h reˉspectively.CONCLUSION:The preparation procedure for doxofylline sustained-release capsules is feasible and repeatable.The capsules have obviously sustained property.
出处 《中国药房》 CAS CSCD 2004年第3期155-156,共2页 China Pharmacy
关键词 多索茶碱 缓释剂 体外释药 doxofylline sustained-release agent in vitro release of drug
  • 相关文献

参考文献1

二级参考文献8

  • 1 Franzone JS,Cirillo R, Biffignandi P. Doxofylline exerts a prophylactic effect againstbronchocostriction and pleurisy induced by PAF[J]. Eur J Pharmacol, 1989, 165(2)∶269
  • 2 Grossi E, Franzone JS, Biffignandi P,et al. Effect of doxofylline, a novelbronchodilator, and theophylline in reversible COPD patients[J]. J Clin Pharm Ther,1988, 45∶168 [3] Lagana A, Bizzarri M, Marino A,et al. Soild phase extration and highperformance liquid chromatographic determination of doxophylline in plasma[J]. BiomedChromatogr, 1990, 4(5)∶205
  • 3 Bolona E,Lagana A,Terracino D,et al. Oral and intravenous pharmacokineticprofiles of doxofylline in patients with chronic bronchitis[J]. J Int MedRes,1990,18(4)∶282
  • 4 Franzone JS, Cravanzola C, Masera F. Preliminary studies of theabsorption,distribution and excretion of 2-(7'-thephyllinoemethyl)-1,3-dioxolane in rat[J].Farmaco Sci, 1981, 36 (3)∶220
  • 5 Stavaric B. Methylxanthines: toxicity to humans. 1: Theophylline[J]. JChem Toxicol, 1988, 26∶541
  • 6 加藤隆一,钅 兼 哲也编.药物代谢学[M].第3版.东京:东京化学同人,1997.51~61
  • 7 Viillani F, De Maria P, Ronchi E, et al. Oral doxophylline in patients withchronic obstructive pulmonary disease[J]. Int J Clin Pharmacol Ther Toxicol, 1997, 35(3)∶107
  • 8 Grosa G, Franzone JS,Biglino G. Metabolism of doxofylline by rat livermicrosomes[J]. Am Sci Pharmacol & Exp Ther,1986,14 (2)∶33 (收稿:2000-01-14  修回:2000-03-01)

共引文献33

同被引文献23

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部